T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Myriad Genetics
MYGN
$476M
| $410K | ﹤0.01% |
91,050
+16,508
| +22% | +$86K |
|
|
NIQ
2527
NIQ Global Intelligence PLC
NIQ
$3.53B
| $410K | ﹤0.01% |
36,006
+14,122
| +65% | +$190K |
|
2528
Republic Bancorp
RBCAA
$1.96B
| $408K | ﹤0.01% |
5,775
+969
| +20% | +$68.4K |
|
2529
Forward Air
FWRD
$461M
| $407K | ﹤0.01% |
24,343
+5,548
| +30% | +$135K |
|
2530
Titan Machinery
TITN
$420M
| $407K | ﹤0.01% |
24,294
+1,930
| +9% | +$33.5K |
|
2531
Zevra Therapeutics
ZVRA
$578M
| $407K | ﹤0.01% |
43,616
+11,476
| +36% | +$103K |
|
|
RZLV
2532
Rezolve AI
RZLV
$893M
| $404K | ﹤0.01% |
157,600
+69,128
| +78% | +$195K |
|
2533
Evolus
EOLS
$397M
| $403K | ﹤0.01% |
97,964
+12,600
| +15% | +$61.1K |
|
2534
Park-Ohio Holdings
PKOH
$550M
| $403K | ﹤0.01% |
16,741
+5,347
| +47% | +$131K |
|
|
OLP
2535
One Liberty Properties
OLP
$542M
| $402K | ﹤0.01% |
18,704
+1,284
| +7% | +$28.5K |
|
2536
Maravai LifeSciences
MRVI
$972M
| $399K | ﹤0.01% |
140,766
+24,773
| +21% | +$84K |
|
2537
Community Health Systems
CYH
$382M
| $398K | ﹤0.01% |
135,194
+8,172
| +6% | +$26.5K |
|
2538
4D Molecular Therapeutics
FDMT
$502M
| $396K | ﹤0.01% |
42,447
+3,700
| +10% | +$32.2K |
|
2539
Navigator Holdings
NVGS
$1.35B
| $395K | ﹤0.01% |
20,417
+832
| +4% | +$15.8K |
|
2540
Shutterstock
SSTK
$209M
| $395K | ﹤0.01% |
23,737
+2,767
| +13% | +$48.7K |
|
2541
Yext
YEXT
$573M
| $394K | ﹤0.01% |
102,356
+18,925
| +23% | +$114K |
|
|
MITT
2542
TPG Mortgage Investment Trust
MITT
$228M
| $393K | ﹤0.01% |
53,731
+5,076
| +10% | +$42K |
|
2543
First United
FUNC
$289M
| $392K | ﹤0.01% |
10,672
-1,000
| -9% | -$37.2K |
|
|
SRG
2544
Seritage Growth Properties
SRG
$138M
| $391K | ﹤0.01% |
138,856
+40,600
| +41% | +$127K |
|
2545
Hallador Energy
HNRG
$646M
| $390K | ﹤0.01% |
23,920
+5,712
| +31% | +$106K |
|
2546
iHeartMedia
IHRT
$531M
| $390K | ﹤0.01% |
133,221
+14,264
| +12% | +$47.2K |
|
2547
Mama's Creations
MAMA
$846M
| $390K | ﹤0.01% |
25,367
+4,675
| +23% | +$71K |
|
2548
Alerus Financial
ALRS
$828M
| $387K | ﹤0.01% |
16,282
+2,688
| +20% | +$65.2K |
|
2549
Royal Bank of Canada
RY
$287B
| $387K | ﹤0.01% |
2,390
| – | – |
|
2550
FerroAtlántica
GSM
$590M
| $385K | ﹤0.01% |
93,280
+22,573
| +32% | +$109K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.